Susan Lu

Author PubWeight™ 9.45^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.	Am J Respir Crit Care Med	2015	1.70
2	Topiramate-associated secondary angle-closure glaucoma: a case series.	Arch Ophthalmol	2002	1.55
3	Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs.	J Clin Psychiatry	2003	0.99
4	Array of molecularly mediated thin film assemblies of nanoparticles: correlation of vapor sensing with interparticle spatial properties.	J Am Chem Soc	2007	0.98
5	Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.	Ann Allergy Asthma Immunol	2002	0.95
6	Effect of montelukast for treatment of asthma in cigarette smokers.	J Allergy Clin Immunol	2013	0.90
7	Quality assurance of asthma clinical trials.	Control Clin Trials	2002	0.81
8	Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.	Pharmacoepidemiol Drug Saf	2010	0.81
9	Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis.	J Clin Pharmacol	2008	0.78
10	Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.	Allergy Asthma Proc	2011	0.75